Literature DB >> 29656808

Injections for Knee Osteoarthritis: Corticosteroids, Viscosupplementation, Platelet-Rich Plasma, and Autologous Stem Cells.

David M Levy1, Kyle A Petersen1, Margie Scalley Vaught2, David R Christian1, Brian J Cole3.   

Abstract

This article reviews the benefits of corticosteroid, viscosupplementation, platelet-rich plasma, and autologous mesenchymal stem cell injections for the treatment of patients with knee osteoarthritis. Integrating injections into both clinical and surgical practices is complicated given existing health insurance reimbursement policies. This review describes the outcomes associated with these interventions and appropriate methods of navigating the existing reimbursement pathways to help providers implement these treatments into their practices.
Copyright © 2018 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29656808     DOI： 10.1016/j.arthro.2018.02.022

Source DB:  PubMed          Journal:  Arthroscopy        ISSN： 0749-8063            Impact factor:   4.772


  12 in total

1.  Intra-Articular Injections of Allogeneic Mesenchymal Stromal Cells vs. High Molecular Weight Hyaluronic Acid in Dogs With Osteoarthritis: Exploratory Data From a Double-Blind, Randomized, Prospective Clinical Trial.

Authors:  Sohyun Kim; Lindsay Elam; Valerie Johnson; Ann Hess; Tracy Webb; Steven Dow; Felix Duerr
Journal:  Front Vet Sci       Date:  2022-06-07

2.  Intra-Articular Injection of Amniotic Membrane and Umbilical Cord Particulate for the Management of Moderate to Severe Knee Osteoarthritis.

Authors:  Olivia G Mead; Leon P Mead
Journal:  Orthop Res Rev       Date:  2020-10-19

Review 3.  Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee.

Authors:  Corey S Cook; Patrick A Smith
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 4.  Effectiveness of AD-MSCs injections for the treatment of knee osteoarthritis: Analysis of the current literature.

Authors:  Angelo V Vasiliadis; Nikiforos Galanis
Journal:  J Stem Cells Regen Med       Date:  2020-05-27

5.  Recent Advances in Clinical Translation of Intra-Articular Osteoarthritis Drug Delivery Systems.

Authors:  Carlisle R DeJulius; Shubham Gulati; Karen A Hasty; Leslie J Crofford; Craig L Duvall
Journal:  Adv Ther (Weinh)       Date:  2020-09-28

Review 6.  Treatment Options for Patellofemoral Arthritis.

Authors:  Anne Kuwabara; Mark Cinque; Taylor Ray; Seth Lawrence Sherman
Journal:  Curr Rev Musculoskelet Med       Date:  2022-02-04

7.  Cartilage Restoration Using Dehydrated Allogeneic Cartilage, Platelet-Rich Plasma, and Autologous Cartilage Mixture Sealed With Activated Autologous Serum.

Authors:  Tracy M Tauro; Abbott Gifford; Eric D Haunschild; Ron Gilat; Michael C Fu; Brian J Cole
Journal:  Arthrosc Tech       Date:  2020-06-15

Review 8.  BRAZILIAN CONSENSUS STATEMENT ON VISCOSUPPLEMENTATION OF THE KNEE (COBRAVI).

Authors:  Gustavo Constantino de Campos; Eduardo Branco de Sousa; Paulo César Hamdan; Cyro Scala de Almeida; Antonio Martins Tieppo; Marcia Uchôa de Rezende; Adrieni Antunes do Amaral Alchaar; Carlos Bruno Pinheiro; Eduardo de Melo Carvalho Rocha; Fabiano Gonçalves Cunha; Ivan Pacheco; Mário Sérgio Rossi Vieira; Sílvio Figueira Antonio; Zartur José Barcelos Menegassi
Journal:  Acta Ortop Bras       Date:  2019 Jul-Aug       Impact factor: 0.513

9.  Viscosupplementation improves pain, function and muscle strength, but not proprioception, in patients with knee osteoarthritis: a prospective randomized trial.

Authors:  Phelippe Augusto Valente Maia; Victor Rodrigues Amaral Cossich; José Inacio Salles-Neto; Diego Pinheiro Aguiar; Eduardo Branco de Sousa
Journal:  Clinics (Sao Paulo)       Date:  2019-11-25       Impact factor: 2.365

Review 10.  Procedural Treatments for Knee Osteoarthritis: A Review of Current Injectable Therapies.

Authors:  Lisa M Billesberger; Kyle M Fisher; Yawar J Qadri; Richard L Boortz-Marx
Journal:  Pain Res Manag       Date:  2020-02-18       Impact factor: 3.037
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.